SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received a delisting...